logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Corneal Ulcer

    Medications for Corneal Ulcer

    FiltersReset Filters
    16 results

    • ciprofloxacin hydrochloride

      (CIPROFLOXACIN HYDROCHLORIDE)
      Advagen Pharma Limited
      Usage: Ciprofloxacin ophthalmic solution is indicated for treating infections due to susceptible microorganisms, specifically for corneal ulcers caused by Pseudomonas aeruginosa, Staphylococcus aureus, and others, as well as conjunctivitis caused by Haemophilus influenzae and related species. Efficacy for certain organisms is based on limited studies.

    • dexamethasone

      (Dexamethasone)
      Rising Pharma Holdings, Inc.
      Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, collagen diseases, severe allergic states, ophthalmic and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and certain miscellaneous conditions, as well as for diagnostic testing of adrenocortical hyperfunction.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Mylan Institutional LLC
      Usage: This drug is indicated for various conditions, including adrenal insufficiencies, rheumatic disorders, collagen diseases, severe allergic reactions, ophthalmic, gastrointestinal, respiratory, hematologic, and neoplastic diseases, and for reducing edema. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally, depending on the condition.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Civica, Inc.
      Usage: This drug is indicated for various conditions, including endocrine disorders (like adrenocortical insufficiency), rheumatic and collagen diseases, severe allergic reactions, dermatologic and gastrointestinal diseases, respiratory issues, hematologic conditions, neoplastic diseases, and neurological disorders. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally as appropriate.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Fresenius Kabi USA, LLC
      Usage: The drug is indicated for various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., arthritis), collagen diseases, dermatologic diseases, severe allergic conditions, ophthalmic diseases, gastrointestinal and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, nervous system issues, and miscellaneous conditions.

    • hydrocortisone

      (Hydrocortisone)
      Strides Pharma Science Limited
      Usage: Hydrocortisone tablets are indicated for various conditions including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., arthritis), collagen diseases (e.g., lupus), dermatologic diseases (e.g., severe psoriasis), allergic states (e.g., asthma), ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and certain miscellaneous conditions.

    • levofloxacin

      (Levofloxacin)
      BPI LABS LLC
      Usage: Levofloxacin ophthalmic solution is indicated for treating corneal ulcers caused by susceptible strains of Gram-positive bacteria (e.g., Staphylococcus aureus, Streptococcus pneumonia) and Gram-negative bacteria (e.g., Pseudomonas aeruginosa). Its efficacy for some organisms, like Serratia marcescens, is based on limited studies.

    • ocuflox

      (ofloxacin)
      Allergan, Inc.
      Usage: OCUFLOX® ophthalmic solution is indicated for treating bacterial conjunctivitis and corneal ulcers caused by susceptible Gram-positive and Gram-negative bacteria, including Staphylococcus aureus, Streptococcus pneumoniae, and Pseudomonas aeruginosa, among others.

    • ofloxacin

      (Ofloxacin Ophthalmic Solution USP, 0.3%)
      SOLA Pharmaceuticals, LLC
      Usage: Ofloxacin ophthalmic solution is indicated for treating bacterial infections in the eye, specifically conjunctivitis and corneal ulcers, caused by susceptible Gram-positive and Gram-negative bacteria, including strains like Staphylococcus aureus and Pseudomonas aeruginosa.

    • ofloxacin

      (OFLOXACIN)
      Leading Pharma, LLC
      Usage: Ofloxacin ophthalmic solution is indicated for treating infections caused by susceptible bacteria in conjunctivitis and corneal ulcers. It targets both Gram-positive and Gram-negative bacteria, including organisms like Staphylococcus aureus and Pseudomonas aeruginosa. Additionally, it addresses certain anaerobic species, such as Propionibacterium acnes.